The use of pamidronate in PTHrP associated hypercalcaemia in infancy

Journal of Pediatric Endocrinology and Metabolism

Volumn 10, Issue 3, 1997, Pages 301-304

  Buckmaster, Adam ^a   Rodda, Christine ^c   Cowell, Chris T ^a,d   Ogle, Graham ^a   Dorney, Stuart ^b  

^a Ray Williams Inst Paediatr E   (Australia)

^b Department of Gastroenterology   (United States)

^c MONASH UNIVERSITY   (Australia)

^d CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

Author keywords

Embryonal renal tumours; Hypercalcaemia; Idiopathic neonatal iron storage disease; Infancy; Pamidronate; PTHrP

Indexed keywords

ALPHA TOCOPHEROL; CALCITONIN; FUROSEMIDE; PAMIDRONIC ACID; PARATHYROID HORMONE RELATED PROTEIN; PREDNISOLONE; RETINOL; SPIRONOLACTONE; VITAMIN D; VITAMIN K GROUP;

CASE REPORT; CHILD; CHILDHOOD DISEASE; CONFERENCE PAPER; DRUG EFFICACY; DRUG USE; HUMAN; HYPERCALCEMIA; INTRAVENOUS DRUG ADMINISTRATION; IRON STORAGE; KIDNEY TUMOR; MALE;

EID: 0030966577     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.1997.10.3.301     Document Type: Conference Paper

References (9)

1. Moseley JM, Gillespie M.T. Parathyroid hormonerelated protein, Clin Rev Clin Lab Sci 1995; 32: 299-343.
2. Jayabose S, Iqbal K, Newman L, San Filippo JA, Davidian MM, Noto R, Sagel I. Hypercalcemia in Childhood Renal Tumors. Cancer 1988; 61: 788-791.
3. Lakhdir F, Lawson D. & Schatz DA Fatal parathyroid hormone-related protein-induced humeral hypercalcemia of malignancy in a 3-month-old infant. Eur J Pediatr 1994; 153: 718-720.
4. Rodda CP, Billson A, Downie P, Cussen L, Chow CW, Hards D, Danks J. Parathyroid hormone-related protein (PTHrP) is associated with unusual childhood renal tumours. Bone 1995; 16 (suppl): 128S,172.
5. Nussbaum SR, Neer RM, Potts JT Jr. Medical management of hyperparathyroidism and hypercalcemia. In: de Groote, ed, Endocrinology, Volume 2, Ed 3. WB Saunders Co., 1995; 1094-1105.
6. Boudailliez BR, Pautard BJ, Sebert JL, Kremp O, Piussan CX. Leukaemia-associated hypercalcaemia in a 10-year old boy: effectiveness of aminohydroxy-propylidene bisphosphonate. Paediatr Nephrol 1990; 4: 510-511.
7. van-Persijn-vanMeerten EL, Kroon HM, Papadopoulos SE. Epi- and metaphyseal changes in children caused by administration of bisphosphonates. Radiology 1992; 184: 249-254.
8. Samue R, Katz K, Papapoulos SE, Yosipovitch Z, Zaizov R, Liberman U. Aminohydroxy propylidene bisphosphonate (APD) treatment improves the clinical skeletal manifestations of Gaucher's disease. Pediatrics 1994; 94: 385-389
9. Barnard JA, Manci E. Idiopathic neonatal iron-storage disease. Gastroenterology 1991; 101: 1420-1427.